SPRY4 and non-small cell lung carcinoma: The expression level of EZH2 was negatively correlated with SPRY4-IT1 expression levels in NSCLC tissues (Figure 2c), and increased EZH2 expression in NSCLC tissues significantly correlated with tumor size, advanced pathological stage, and lymph node metastasis (Supplementary Table 5).